Posted: Dec 14, 2020 5:23 PM CT | Last Updated: December 14, 2020 U of M researchers have found a potential Neuregulin-1 beta 1 protein treatment for MS that could balance out the immune system and slow disease progression.(CBC) Researchers at the University of Manitoba have uncovered a potential treatment for multiple sclerosis (MS) that could also help predict if someone might develop the disease. The new study, led by Hardeep Kataria (PhD) and published this week in the peer-reviewed neurology journal Brain, focuses on cell protein Neuregulin-1 beta 1. Researchers found a link between a decline in Neuregulin-1 beta 1 levels and the onset — and progression — of MS.